Variations in antenatal corticosteroid therapy: A persistent problem despite 30 years of evidence

Obstetrics and Gynecology

Volumn 99, Issue 3, 2002, Pages 401-408

  Chien, Li Yin ^a   Ohlsson, Arne ^b   Seshia, Mary M K ^c   Boulton, Jill ^d   Sankaran, Koravangattu ^e   Lee, Shoo K ^f,g,h  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g Health Evaluation Research   (Canada)

^h Canadian Neonatal Network   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DATA ANALYSIS; FEMALE; HOSPITAL; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEWBORN DEATH; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT MORTALITY; INFANT, NEWBORN; LOGISTIC MODELS; MALE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PRENATAL CARE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK FACTORS;

EID: 0036185580     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(01)01732-X     Document Type: Article

References (28)

1. A controlled trial of antepartum glucocorticoid treatment for prevention of respiratory distress syndrome in premature infants
2. Prophylactic corticosteroids for preterm birth (Cochrane Review)
3. Antenatal corticosteroid therapy to prevent respiratory distress syndrome
4. Increasing use of antenatal corticosteroid therapy between 1990 and 1993 in Vermont Oxford Network
5. Variations in practice and outcomes in the Canadian NICU Network: 1996-1997
6. Abnormal pulmonary outcomes in preterm infants: Prediction from oxygen requirement in the neonatal period
7. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1500 g
8. Neonatal necrotizing enterocolitis. Therapeutic decisions based on clinical staging
9. An international classification of retinopathy of prematurity
10. A classification of retrolental fibroplasia
11. Extra hospital stay and antibiotic usage with nosocomial coagulase negative staphylococcal bacteremia in two neonatal intensive care unit populations
12. Meta-analysis of randomized controlled trials of antenatal corticosteroid for the prevention of respiratory distress syndrome: Discussion
13. Single-versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome
14. An exploration of opinion and practice patterns affecting low use of antenatal corticosteroids
15. Obstetrician-gynecologists' knowledge and training about antenatal corticosteroids
16. Why don't physicians follow clinical practice guidelines? A framework for improvement
17. Changes in tonsillectomy rates associated with feedback and review
18. Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation
19. Glucocorticoid exposure in utero: New model for adult hypertension
20. Antenatal corticosteroid prescribing: Setting standards of care
21. The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestations with premature rupture of membranes
22. Treatments of preterm premature rupture of the membranes: A meta analysis
23. Do antenatal corticosteroids help in the setting of preterm rupture of membranes?
24. Neonatal sepsis after betamethasone administration to patients with preterm premature rupture of membranes
25. Observational evidence for the efficacy of antenatal steroids from randomized studies of surfactant replacement
26. Late onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network
27. Antenatal corticosteroid treatment and neonatal outcomes for infants 501 to 1500 grams in the Vermont-Oxford Trials Network